ϳäïèñàòèñü
³êòîð³ÿ ˳ïñîí
³êòîð³ÿ ˳ïñîí
ÄÓ "²íñòèòóò ïðîáëåì åíäîêðèííî¿ ïàòîëî㳿 ³ì. Â.ß.Äàíèëåâñüêîãî ÍÀÌÍ Óêðà¿íè"
ϳäòâåðäæåíà åëåêòðîííà àäðåñà â ipep.com.ua
Íàçâà
Ïîñèëàííÿ
Ïîñèëàííÿ
гê
Àçîëîàçèíîâ³ ñèñòåìè ç ÷àñòêîâî ã³äðîãåí³çîâàíèì àçèíîâèì ôðàãìåíòîì
 ˳ïñîí
―Õ., 2007.―33 ñ, 2007
52007
Ñèíòåç 7-àðèë-6, 7-äèã³äðîòåòðàçîëî [1, 5-a] ï³ðèì³äèí-5 (4H)-îí³â
NV Svitlichna, VV Borodina, VV Lipson, VI Musatov
Journal of Organic and Pharmaceutical Chemistry 12 (1 (45)), 47-50, 2014
22014
Äîì³íî-ðåàêö³¿ ³çàòèí³â ç 5-àì³íîï³ðàçîëàìè òà 2, 2-äèìåòèë-1, 3-ä³îêñàí-4, 6-ä³îíîì
NI Zemlyana, TM Karnozhitska, TL Pavlovska, OV Mazepa, VI Musatov, ...
Journal of Organic and Pharmaceutical Chemistry 16 (4 (64)), 3-10, 2018
12018
Õ³ì³÷í³ âëàñòèâîñò³ 3-(5-àì³íî-1Í-1, 2, 4-òðèàçîë-1-³ë)-òà 3-(2-àì³íî-1Í-áåíçî
Í Ñâ³òëè÷íà, ÎÎ Øèøê³íà,  Áîðîä³íà, Ôà ßðåìåíêî,  ˳ïñîí, ...
Æóðíàë îðãàí³÷íî¿ òà ôàðìàöåâòè÷íî¿ õ³ì³¿, ³ì³äàçîë-1-³ë)-3 …, 2014
12014
STUDY OF SPECIFIC ANTIDIABETIC EFFECT OF PERSPECTIVE SIRTUIN-1 ACTIVATOR PYRABENTIN ON THE MODEL OF METABOLIC MEMORY IN RATS
N Krasova, A Gladkih, F Yaremenko, Z Leshchenko, A Kolesnikova, ...
Problems of Endocrine Pathology 76 (2), 71-77, 2021
2021
ÍÈÇÜÊÎÌÎËÅÊÓËßÐͲ ÃÅËÅÓÒÂÎÐÞÂÀײ ÍÀ ÎÑÍβ ÏÎÕ²ÄÍÈÕ ÑÒÅÐίIJ ÒÀ ÏÅÍÒÀÖÈÊ˲×ÍÈÕ ÒÐÈÒÅÐÏÅÍίIJÂ
 ˳ïñîí, Ê Êóëèê
2021
Äîì³íî-ðåàêö³¿ 3-ìåòèë-5-àì³íîï³ðàçîëó ç 1-ôåí³ë-3-(4-àëêîêñèôåí³ë) ï³ðàçîë-4-êàðáàëüäåã³äàìè òà 2, 2-äèìåòèë-1, 3-ä³îêñàí-4, 6-ä³îíîì
OM Semenenko, VV Lipson, VV Mironova, LV Budianska, VI Musatov, ...
Journal of Organic and Pharmaceutical Chemistry 18 (1 (69)), 45-51, 2020
2020
EFFECTS OF PERSPECTIVE SIRTUIN-1 ACTIVATOR ON ENERGY HOMEOSTASIS CONSTITUENTS IN RATS WITH E XPERIMENTAL T YPE 2 DIABETES MELLITUS AT THE BACKGROUND OF OBESITY
N Krasova, AI Gladkih, F Yaremenko, TV Tyzhnenko, Z Leshchenko, ...
Problems of Endocrine Pathology 70 (4), 116-122, 2019
2019
Ìîäèô³êàö³ÿ ñòåðî¿äíî¿ ìîëåêóëÿðíî¿ ïëàòôîðìè äëÿ ñòâîðåííÿ íîâèõ õ³ðàëüíèõ äîáàâîê.
 Ìèðîíîâà,  ˳ïñîí, ÎÌ Ñåìåíåíêî
Õ³ì³÷í³ ïðîáëåìè ñüîãîäåííÿ, 93-93, 2019
2019
Åôåêòè ïåðñïåêòèâíîãî àêòèâàòîðà ñ³ðòó¿íó-1 íà ñêëàäîâ³ åíåðãåòè÷íîãî ãîìåîñòàçó ó ùóð³â ç åêñïåðèìåíòàëüíèì öóêðîâèì ä³àáåòîì 2 òèïó íà òë³ îæèð³ííÿ
ÍÑ Êðàñîâà, β Ãëàäêèõ, Ôà ßðåìåíêî, Ò Òèæíåíêî, ÆÀ Ëåùåíêî, ...
Ïðîáëåìè åíäîêðèííî¿ ïàòîëî㳿, 116-122, 2019
2019
Ñèíòåç òà àíàë³ç ÿêîñò³ ñóáñòàíö³¿ 7, 8-äèã³äðî-3, 7, 7-òðèìåòèë-4-ñòèðèë-2H-ï³ðàçîëî-I3, 4-BI õ³íîë³í-5 (4í, 6í, 9í)-îíó–íîâî¿ á³îëîã³÷íî àêòèâíî¿ ñïîëóêè ç êîìïëåêñíîþ …
Ͳ Çåìëÿíà, Ñ Êðàâ÷åíêî, ˪ ͳê³øèíà,  ˳ïñîí
³ñíèê Õàðê³âñüêîãî íàö³îíàëüíîãî óí³âåðñèòåòó ³ìåí³ ÂÍ Êàðàç³íà. Ñåð³ÿ …, 2017
2017
ÕÈÌÈ×ÅÑÊÈÅ ÑÂÎÉÑÒÂÀ 3-(5-ÀÌÈÍÎ-1Í-1, 2, 4-ÒÐÈÀÇÎË-1-ÈË)-È 3-(2-ÀÌÈÍÎ-1Í-ÁÅÍÇÎ [d] ÈÌÈÄÀÇÎË-1-ÈË)-3-ÔÅÍÈËÏÐÎÏÀÍÃÈÄÐÀÇÈÄÎÂ
Í Ñâ³òëè÷íà, ÎÎ Øèøê³íà,  Áîðîä³íà, Ôà ßðåìåíêî,  ˳ïñîí, ...
Æóðíàë îðãàí³÷íî¿ òà ôàðìàöåâòè÷íî¿ õ³ì³¿ 12 (3), 74-80, 2014
2014
Åôåêò ïîòåíö³éíîãî ³íã³á³òîðà 11-áåòà-ã³äðîêñèñòåðî¿ä-äåã³äðîãåíàçè 1 òèïó íà ôóíêö³îíàëüíî-ìåòàáîë³÷í³ ïîêàçíèêè ó ùóð³â ç åêñïåðèìåíòàëüíèì öóêðîâèì ä³àáåòîì
ÍÑ Êðàñîâà, β Ãëàäêèõ, ÆÀ Ëåùåíêî, Ò Òèæíåíêî, ÞÀ Îïàëåéêî, ...
Åíäîêðèíîëîã³ÿ, 314-314, 2014
2014
Âïëèâ ïîòåíö³éíîãî ³íã³á³òîðó 11-áåòà-ã³äðîêñèñòåðî¿ä-äåã³äðîãåíàçè 1 òèïó íà ³íñóë³íîðåçèñòåíòí³ñòü ó ùóð³â ç åêñïåðèìåíòàëüíèì öóêðîâèì ä³àáåòîì
Í Êðàñîâà, Î Ãëàäêèõ, Æ Ëåùåíêî, Ò Çóáàòþê,  ˳ïñîí,  Ïîëòîðàê
Óêðà¿íñüêèé á³îôàðìàöåâòè÷íèé æóðíàë, 20-20, 2013
2013
Ñèíòåç òà õ³ì³÷í³ âëàñòèâîñò³ 5-àðèë-4, 7-äèã³äðî-1, 2, 4-òðèàçîëî [1, 5-a] ï³ðèì³äèí³â
 ˳ïñîí, ²Â ²ãíàòåíêî, Í Ñâ³òëè÷íà,  Áîðîä³íà, Ìà Øèðîáîêîâà, ...
Æóðíàë îðãàí³÷íî¿ òà ôàðìàöåâòè÷íî¿ õ³ì³¿, 2011
2011
ÑÈÍÒÅÇ ² ÀÍÒÈIJÀÁÅÒÈ×ÍÀ ÀÊÒÈÂͲÑÒÜ 4-ÇÀ̲ÙÅÍÈÕ 2Í-ϲÐÀÇÎËÎ [3, 4-B] Õ²ÍÎ˲Í-5-ÎͲÂ
Ͳ Çåìëÿíà,  ˳ïñîí,  Áîðîä³íà, ÒÎ Çóáàòþê,  Ïîëòîðàê, ...
Ç̲ÑÒ/CONTENTS/ÑÎÄÅÐÆÀÍÈÅ
Ͳ Çåìëÿíà, ÒÌ Êàðíîæèöüêà, ÒË Ïàâëîâñüêà, ΠÌàçåïà, ² Ìóñàòîâ, ...
Ôóíêö³îíàëüíî çàì³ùåí³ 7-àëê³ëñåëåíî-1, 4-äèã³äðî-1, 6-íàôòèðèäèíè: ñèíòåç áàãàòîêîìïîíåíòíîþ êîíäåíñàö³ºþ, âëàñòèâîñò³ òà áóäîâà
ÂÄ Äÿ÷åíêî, ÑÌ Äåñåíêî,  ˳ïñîí
Ðåàêö³¿ a-àì³íîàçîë³â ç ïîõ³äíèìè íåíàñè÷åíèõ êèñëîò ³ êåòîí³â
 ˳ïñîí, ÂÄ Äÿ÷åíêî, ÍÌ Êîëîñ
×àñòêîâî ã³äðîãåí³çîâàí³ ï³ðàçîëî-òà 1, 2, 4-òðèàçîëî [1, 5-a] ï³ðèì³äèíè: ñèíòåç, õ³ì³÷í³ âëàñòèâîñò³, òàóòîìåð³ÿ
 ˳ïñîí, ²Â Óêðà¿íåöü, ÍÌ Êîëîñ
Ó äàíèé ìîìåíò ñèñòåìà íå ìîæå âèêîíàòè îïåðàö³þ. Ñïðîáóéòå ï³çí³øå.
Ñòàòò³ 1–20